With its extremely high levels of caffeine, a hip new soft drink is raising fears in the United States that it might be dangerous for children, who have been snapping up the beverage since it was launched by famous YouTube ...
Jul 15, 2023
0
16
A new blood test approved by the U.S. Food and Drug Administration can predict imminent preeclampsia, helping pregnant women who are at risk of this severe and sometimes deadly form of high blood pressure.
Jul 5, 2023
0
1
An experimental drug appears to outperform the trendy medications Wegovy and Ozempic for both weight loss and diabetes control, a pair of early clinical trials shows.
Jun 27, 2023
0
1
Amid the buzz around weight loss drugs and rising rates of obesity worldwide, many health care professionals are questioning one of the key measures that has long been used to define obesity.
Jun 26, 2023
0
7
A new study in rats suggests that xylazine, the active ingredient in a non-opioid veterinary tranquilizer not approved for human use, can worsen the life-threatening effects of opioids.
Jun 20, 2023
0
26
Imagine struggling to remember your loved ones, the places you've been or even your own name. The haunting reality of Alzheimer's disease and dementia is a terrifying prospect for many individuals and their families.
Jun 15, 2023
0
4
Doctors in England's state-run health service could soon be allowed to prescribe more people with obesity weight-loss drugs under a new pilot scheme, the government said Wednesday.
Jun 7, 2023
0
2
Dementia is defined as the loss of cognitive functioning—including thinking, remembering, and reasoning—and is very prevalent in Japan. Currently, the treatment satisfaction for dementia is among the lowest and no drug ...
May 29, 2023
0
52
Outside advisors for the U.S. Food and Drug Administration voted Thursday to recommend approval of Neffy, the first epinephrine nasal spray for severe allergic reactions.
May 12, 2023
0
3
U.S. regulators are urging Americans to avoid Apetamin, an illegal drug used for weight gain and figure enhancement.
May 2, 2023
0
9
